DNB
43
-8
HST
70
27
QRVO
29
5
DHI
68
2
CMA
53
-12
V
50
-2
AIZ
61
-3
FSLR
41
-3
GWW
53
-2
CTXS
52
11
DAL
53
3
KMX
47
-5
BIIB
42
-3
CMG
69
6
DOW
36
-3
SE
41
-3
O
52
-4
FLR
48
-4
VMC
41
3
IBM
54
-6
DNB
43
-8
HST
70
27
QRVO
29
5
DHI
68
2
CMA
53
-12
V
50
-2
AIZ
61
-3
FSLR
41
-3
GWW
53
-2
CTXS
52
11
DAL
53
3
KMX
47
-5
BIIB
42
-3
CMG
69
6
DOW
36
-3
SE
41
-3
O
52
-4
FLR
48
-4
VMC
41
3
IBM
54
-6
Financhill
Back

Moderna Quote, Financials, Valuation and Earnings

Buy
71

MRNA
Moderna

Last Price:
159.56
Seasonality Move:
8.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Moderna Price Quote

$159.56
+4.02 (+2.58%)
(Updated: July 6, 2022 at 6:40 PM ET)

Moderna Key Stats

Buy
71
Moderna (MRNA) is a Buy
Day range:
$146.84 - $158.79
52-week range:
$115.61 - $497.49
Dividend yield:
0%
P/E ratio:
5.50
P/S ratio:
2.96
P/B ratio:
3.62%
Volume:
6M
Avg. volume:
5.6M
1-year change:
-33.62%
Market cap:
$61.9B
Revenue:
$18.5B
EPS:
$34.03

How Much Does Moderna Make?

  • How Much Are Moderna's Sales Annually?
    MRNA Revenues are $18.5B
  • How Much Profit Does Moderna's Make A Year?
    MRNA net income is $12.2B

Is Moderna Growing As A Company?

  • What Is Moderna's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.13%
  • What Is Moderna's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 2.02%

Moderna Stock Price Performance

  • Did Moderna Stock Go Up Last Month?
    Moderna share price went up by 13.41% last month
  • Did MRNA's Share Price Rise Over The Last Year?
    MRNA share price fell by -33.62% over the past 1 year

What Is Moderna 52-Week High & Low?

  • What Is Moderna’s 52-Week High Share Price?
    Moderna has traded as high as $497.49 over the past 52 weeks
  • What Is Moderna’s 52-Week Low Share Price?
    Moderna has traded as low as $115.61 over the past 52 weeks

Moderna Price To Free Cash Flow

  • Is Moderna Stock Overvalued?
    Moderna is trading at a price to free cash flow ratio of 5.14
  • Is Moderna Stock Undervalued?
    Moderna EV to Free Cash Flow ratio is 3.97
  • What Is Moderna’s Price Earnings Growth Ratio?
    MRNA PEG ratio is 0.00
  • Is Moderna Trading At A Premium To Earnings?
    Moderna EV to EBIT ratio is 3.18

Is It Risky To Buy Moderna?

  • How Much Debt Does Moderna Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Moderna Have?
    Cash and short term investments quarterly total is $10.1B
  • What Is Moderna’s Book Value Per Share?
    Book value per share is 42.69

Is Moderna Cash Flow Positive?

  • What Is MRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is $13.4B
  • What Is Moderna’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.5B
  • What Is Moderna’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.3B

Moderna Return On Invested Capital

  • Is Management Doing A Good Job?
    MRNA return on invested capital is 141.06%
  • What Is Moderna Return On Assets?
    ROA measures how assets are converting to revenues and is 71.72%
  • What Is MRNA Return On Equity?
    ROE is a measure of profitability and is 141.06%

Moderna Earnings Date & Stock Price

  • What Is Moderna's Stock Price Today?
    A single share of MRNA can be purchased today for 155.54
  • What Is Moderna’s Stock Symbol?
    Moderna trades on the nasdaq under the ticker symbol: MRNA
  • When Is Moderna’s Next Earnings Date?
    The next quarterly earnings date for Moderna is scheduled on August 5, 2022
  • When Is MRNA's next ex-dividend date?
    Moderna's next ex-dividend date is July 6, 2022
  • How To Buy Moderna Stock?
    You can buy Moderna shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Moderna Competitors

  • Who Are Moderna's Competitors?
    Below is a list of companies who compete with Moderna or are related in some way:
    • Johnson & Johnson (JNJ)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Vertex Pharmaceuticals Inc (VRTX)

Moderna Dividend Yield

Data Unavailable

Moderna Analyst Estimates

YoY Growth Past Surprise
EPS: 202.11% 52.59%
Revenue: 213.17% 37.06%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 10
Sell Recommendations: 0
Price Target: 213.67
Upside from Last Price: 37.37%

Major Shareholders

  • How many MRNA shares are owned by institutional investors?
    424.8M MRNA shares are owned by institutional investors
  • How many MRNA shares are owned by insiders?
    22.9M MRNA shares are owned by insiders